Emamectin benzoate

Emamectin benzoate



Effects reported: Mortality Enzyme(s) Biochemistry Feeding behavior Cell(s) Growth Physiology Genetics Development
← Scroll →
ⓘ Table glossary
Table glossary
ReferencePubMed ID of research paper
Experimental TypeIn vivo or in vitro
Cell / TissueIf in vitro, cells derived from aquaculture-relevant species
Cell / TissueIf in vitro, tissues obtained from aquaculture-relevant species
Cell / TissueIf in vivo, left blank
Test OrganismAquaculture-relevant species tested for toxic effect
LifestageLifestage of the test organism if mentioned in the reference
AdministrationRoute by which the chemical enters the test organism or treatment method
Administered dose rangeDifferent doses of chemicals tested in this study
Significant dose rangeSignificant result(s) at specific doses
Trend Direction of effect over time
Measurement Parameter used to quantify the effect
Effect Overall observed biological outcome or toxicological effect
Reference Experiment type Cell / tissue Test organism Lifestage Administration Administered dose Significant dose Trend Measurement Effect
PMID:34628582 In vivo - Oncorhynchus gorbuscha Fry Sediment treatment 300.0-2065.0
μg/kg		 300.0-2065.0
μg/kg		 Decreased Lethal body concentration Mortality
In vivo - Oncorhynchus gorbuscha Fry Sediment treatment 100.0-300.0
μg/kg		 100.0-300.0
μg/kg		 Decreased Subchronic/Chronic toxic concentration Mortality
In vivo - Oncorhynchus gorbuscha Fry Water treatment 100.0-1090.0
µg/L		 100.0-1090.0
µg/L		 Decreased Lethal body concentration Mortality
In vivo - Oncorhynchus gorbuscha Fry Water treatment 30.0-100.0
µg/L		 30.0-100.0
µg/L		 Decreased Subchronic/Chronic toxic concentration Mortality
PMID:34728388 In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Acetylcholinesterase (AChE) Enzyme(s)
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Calcium content Biochemistry
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Chloride Biochemistry
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Food consumption Feeding behavior
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Superoxide dismutase (SOD) enzyme activity Enzyme(s)
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Decreased Survival Mortality
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Increased Alkaline phosphatase Enzyme(s)
In vivo - Oreochromis niloticus Fry Feed 50.0-500.0
μg		 50.0-500.0
μg		 Increased Glucose Biochemistry
PMID:37431061 In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Acetylcholinesterase (AChE) Enzyme(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Calcium content Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Chloride Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Food consumption Feeding behavior
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Hematocrit (anemia) Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Hemoglobin Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Monocyte Cell(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Decreased Polychromatic cells Cell(s)
In vivo - Oreochromis niloticus - Diet 150
μg/kg/day		 150
μg/kg/day		 Decreased Survival Mortality
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Alanine transaminase (ALT) Enzyme(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Alkaline phosphatase Enzyme(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Aspartate aminotransferase Enzyme(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Creatinine Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Glucose Biochemistry
In vivo - Oreochromis niloticus - Diet 150
μg/kg/day		 150
μg/kg/day		 Increased Hemoglobin Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Leukocytes Cell(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Lymphocyte Cell(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Mean corpuscular volume Biochemistry
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Neutrophil Cell(s)
In vivo - Oreochromis niloticus - Diet 50.0-150.0
μg/kg/day		 50.0-150.0
μg/kg/day		 Increased Thrombocytes Cell(s)
PMID:37499828 In vivo - Danio rerio Embryos - 0.5-2.0
mg/L		 0.5-2.0
mg/L		 Decreased Area of subintestinal vessels (SIV) Cell(s)
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Decreased Distance Growth
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Decreased End-diastolic volume Physiology
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Decreased End-systolic volume Physiology
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased Fms related receptor tyrosine kinase 4 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased GATA mRNA Genetics
In vivo - Danio rerio Embryos - 8
mg/L		 8
mg/L		 Decreased Hatch Mortality
In vivo - Danio rerio Embryos - 2
mg/L		 2
mg/L		 Decreased Heart rate Physiology
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Decreased Intersegmental vessels (ISVs) Physiology
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased Kinase insert domain receptor like mRNA Genetics
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Decreased Length of intersegmental vessel Growth
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased Myosin regulatory light chain 7 mRNA Genetics
In vivo - Danio rerio Embryos - 0.1-8.0
mg/L		 4.0-8.0
mg/L		 Decreased Survival Mortality
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased T-box 5a mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Decreased Vascular endothelial growth factor c mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Alpha-induced tumor necrosis factor mRNA Genetics
In vivo - Danio rerio Embryos - 0.5-2.0
mg/L		 0.5-2.0
mg/L		 Increased Apoptosis Cell(s)
In vivo - Danio rerio Embryos - 1.0-2.0
mg/L		 1.0-2.0
mg/L		 Increased Area of cardinal vein (CCV) Growth
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Caspase 8 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Caspase-3 mRNA Genetics
In vivo - Danio rerio Embryos - 0.5-2.0
mg/L		 0.5-2.0
mg/L		 Increased Deformation Development
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased FADD mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Fax mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Interleukin 6 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Interleukin 8 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Interleukin-1 beta mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Myeloid differentiation primary response protein MyD88 mRNA Genetics
In vivo - Danio rerio Embryos - 0.5-4.0
mg/L		 0.5-2.0
mg/L		 Increased Neutrophil Cell(s)
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Nuclear factor kappa B mRNA Genetics
In vivo - Danio rerio Embryos - 0.5-2.0
mg/L		 0.5-2.0
mg/L		 Increased Number of endothelial cells Cell(s)
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased TNF receptor-associated factor 6 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Toll-like receptor 2 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased Toll-like receptor 4 mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased bax mRNA Genetics
In vivo - Danio rerio Embryos - 1
mg/L		 1
mg/L		 Increased p53 mRNA Genetics
ⓘ
Glossary ×
ReferencePubMed ID of research paper
Experimental TypeIn vivo or in vitro
Cell / TissueIf in vitro, cells derived from aquaculture-relevant species
Cell / TissueIf in vitro, tissues obtained from aquaculture-relevant species
Cell / TissueIf in vivo, left blank
Test OrganismAquaculture-relevant species tested for toxic effect
LifestageLifestage of the test organism if mentioned in the reference
AdministrationRoute by which the chemical enters the test organism or treatment method
Administered dose rangeDifferent doses of chemicals tested in this study
Significant dose rangeSignificant result(s) at specific doses
Trend Direction of effect over time
Measurement Parameter used to quantify the effect
Effect Overall observed biological outcome or toxicological effect
⇧
DISCLAIMER

ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.